What is the Melanoma Research Institute of Excellence (MRIE)?
In the fight against cancer, the power of research gives promise to the hope for better treatment and cures. Over the course of more than 20 years, the melanoma team at the Sidney Kimmel Cancer Center has established a robust research program unmatched by any other melanoma program in the world. The establishment of the Melanoma Research Institute of Excellence (MRIE) ensures our patients have access to next-generation therapies for notoriously complex cancers.
The Melanoma Research Institute of Excellence at the Sidney Kimmel Cancer Center (SKCC) is a comprehensive program that brings together uveal melanoma and skin melanoma specialties. These programs have a proven track record for pioneering bench-to-bedside innovations, first-in-field therapies, and a breadth of treatment options. Through lab-based, clinical, genetic, and population-based studies, the MRIE is unlocking insights previously unattainable. The goal of the MRIE is simple: better prevention, diagnosis, and treatment strategies for melanoma patients at SKCC and far beyond.
Research is key. Every new discovery brings us closer to new insights, new detection methodologies, and new therapies. It gives us the direction today that will lead to a cure tomorrow.
MRIE Leadership
The MRIE leadership team is comprised of translational and basic science innovators in the field of uveal melanoma research. These visionary leaders have dedicated their careers to understanding and treating uveal and cutaneous melanoma.
Pilot Awards
Pilot awards serve as an invaluable source of support for the most promising and innovative research projects performed by SKCC investigators and world-class collaborators.
Apply for pilot awards here.
Team Awards
Team awards help bring together the best in the field to collaborate and enable the institution to be competitive for additional government grants and funding. These awards are two years in duration.
Apply for team awards here.